Showing 20 of 223 recruiting trials for “acute-promyelocytic-leukemia”
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia
Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
👨⚕️ Wang Sanbin, MD, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China📍 1 site📅 Started Jul 2025View details ↗
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
👨⚕️ Thomas Knight, MD, Wake Forest University Health Sciences📍 2 sites📅 Started Jun 2025View details ↗
VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
👨⚕️ Roni Tamari, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Jun 2025View details ↗
A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
👨⚕️ Mendel Goldfinger, MD, Montefiore/Einstein Cancer Center📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT07326930 ↗
Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →